The FDA removed Eli Lilly’s LLY tirzepatide injection ... has completed the acquisition of Catalent and sold three manufacturing sites to Novo Nordisk to enhance production capacity for Ozempic ...

and FDA staffing decisions at a Senate hearing. EU says Novo Holdings’ $16.5 billion takeover of US contract development and manufacturing organisation Catalent does not pose antitrust issues.

“The agreement to acquire the three Catalent manufacturing sites ... Neurotech Pharma's cell therapy Encelto has become the first FDA-approved therapy for idiopathic macular telangiectasia ...

SOMERSET, N.J., February 20, 2025--(BUSINESS WIRE)--Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has ...